Polaryx Therapeutics PLYX Growth Metrics (2025-2026)

NASDAQ PLYX
$2.14 -0.02 (-0.93%)
At close: Aug 20, 2026 · 4:00 PM EDT
Growth Metrics Jun2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) (Quarter) 3.38%
Assets (QoQ) (Quarter) -32.26%237.29%
Cash & Equivalents Growth (1y) (Quarter) 11.30%
Cash & Equivalents (QoQ) (Quarter) -40.11%274.74%
Cash from Operations Growth (1y) (Quarter) -190.97%-49.49%
Cash from Operations (QoQ) (Quarter) -25.67%36.57%
EBIT Growth (1y) (Quarter) 61.24%-56.11%
EBIT (QoQ) (Quarter) 82.50%29.52%
EBT Growth (1y) (Quarter) 61.24%-56.11%
EBT (QoQ) (Quarter) 82.50%29.52%
Enterprise Value Growth (1y) (Quarter) -11.30%
Enterprise Value (QoQ) (Quarter) 40.11%-274.74%
EPS (Basic) Growth (1y) (Quarter) 52.72%-26.67%
EPS (Basic) (QoQ) (Quarter) 80.20%46.94%
EPS (Diluted) Growth (1y) (Quarter) 52.72%-26.67%
EPS (Diluted) (QoQ) (Quarter) 80.20%46.94%
Free Cash Flow Growth (1y) (Quarter) -190.97%-49.49%
Free Cash Flow (QoQ) (Quarter) -25.67%36.57%
Net Cash Flow Growth (1y) (Quarter) -349.46%-49.49%
Net Cash Flow (QoQ) (Quarter) -94.12%36.57%
Net Income Growth (1y) (Quarter) 61.24%-56.11%
Net Income (QoQ) (Quarter) 82.50%29.52%
Net Income towards Common Stockholders Growth (1y) (Quarter) 49.64%-36.90%
Net Income towards Common Stockholders (QoQ) (Quarter) 80.05%45.75%
Operating Income Growth (1y) (Quarter) 61.24%-56.11%
Operating Income (QoQ) (Quarter) 82.50%29.52%
Profit After Tax Growth (1y) (Quarter) 49.64%-38.89%
Profit After Tax (QoQ) (Quarter) 80.24%44.97%
Return on Assets (QoQ) (Quarter) 1.00
Share-based Compensation Growth (1y) (Quarter) -89.51%6,937.04%
Share-based Compensation (QoQ) (Quarter) -93.86%0.00%